Enzychem Lifesciences Corporation (KO:183490) — Market Cap & Net Worth
Market Cap & Net Worth: Enzychem Lifesciences Corporation (183490)
Enzychem Lifesciences Corporation (KO:183490) has a market capitalization of $75.56 (₩111.50K) as of April 15, 2026. Listed on the KO stock exchange, this Korea-based company holds position #47496 globally and #2624 in its home market, demonstrating a 12.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Enzychem Lifesciences Corporation's stock price ₩1115.00 by its total outstanding shares 100 (100.00).
Enzychem Lifesciences Corporation Market Cap History: 2016 to 2026
Enzychem Lifesciences Corporation's market capitalization history from 2016 to 2026. Data shows change from $361.13 to $75.56 (-18.52% CAGR).
Enzychem Lifesciences Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Enzychem Lifesciences Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Enzychem Lifesciences Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $361.13 | $21.84 Billion | -$6.33 Billion | 0.00x | N/A |
| 2017 | $475.85 | $26.13 Billion | -$5.67 Billion | 0.00x | N/A |
| 2018 | $882.95 | $31.03 Billion | -$14.42 Billion | 0.00x | N/A |
| 2019 | $628.51 | $31.47 Billion | -$16.88 Billion | 0.00x | N/A |
| 2020 | $940.98 | $25.82 Billion | -$17.51 Billion | 0.00x | N/A |
| 2021 | $620.08 | $22.98 Billion | -$27.86 Billion | 0.00x | N/A |
| 2022 | $112.16 | $26.64 Billion | -$25.09 Billion | 0.00x | N/A |
| 2023 | $123.20 | $76.04 Billion | -$9.33 Billion | 0.00x | N/A |
Competitor Companies of 183490 by Market Capitalization
Companies near Enzychem Lifesciences Corporation in the global market cap rankings as of April 15, 2026.
Key companies related to Enzychem Lifesciences Corporation by market ranking:
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #4747 globally with a market cap of $3.25 Billion USD.
- Fuller Smith & Turner P.L.C (PINK:FTUAF): Ranked #14851 globally with a market cap of $413.74 Million USD.
- ESSO THAILAND NVDR (JAV2.SG) (STU:JAV2): Ranked #17879 globally with a market cap of $228.84 Million USD ( €195.74 Million EUR).
- Nihon Chouzai Co.Ltd (PINK:NHCZF): Ranked #19526 globally with a market cap of $162.79 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #4747 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #14851 | Fuller Smith & Turner P.L.C | PINK:FTUAF | $413.74 Million | $13.93 |
| #17879 | ESSO THAILAND NVDR (JAV2.SG) | STU:JAV2 | $228.84 Million | €0.06 |
| #19526 | Nihon Chouzai Co.Ltd | PINK:NHCZF | $162.79 Million | $16.03 |
Enzychem Lifesciences Corporation Historical Marketcap From 2016 to 2026
Between 2016 and today, Enzychem Lifesciences Corporation's market cap moved from $361.13 to $ 75.56, with a yearly change of -18.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩75.56 | -27.12% |
| 2025 | ₩103.69 | +7.37% |
| 2024 | ₩96.57 | -21.62% |
| 2023 | ₩123.20 | +9.85% |
| 2022 | ₩112.16 | -81.91% |
| 2021 | ₩620.08 | -34.10% |
| 2020 | ₩940.98 | +49.72% |
| 2019 | ₩628.51 | -28.82% |
| 2018 | ₩882.95 | +85.55% |
| 2017 | ₩475.85 | +31.77% |
| 2016 | ₩361.13 | -- |
End of Day Market Cap According to Different Sources
On Apr 15th, 2026 the market cap of Enzychem Lifesciences Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.56 USD |
| MoneyControl | $75.56 USD |
| MarketWatch | $75.56 USD |
| marketcap.company | $75.56 USD |
| Reuters | $75.56 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Enzychem Lifesciences Corporation
Enzychem Lifesciences Corporation operates in Diversified Metals & Mining.